Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study Article

cited authors

  • Fizazi, Karim; Carducci, Michael; Smith, Matthew; Damiao, Ronaldo; Brown, Janet; Karsh, Lawrence; Milecki, Piotr; Shore, Neal; Rader, Michael; Wang, Huei; Jiang, Qi; Tadros, Sylvia; Dansey, Roger; Goessl, Carsten

Publication Date

  • March 5, 2011

webpage

published in

category

start page

  • 813

end page

  • 822

volume

  • 377

issue

  • 9768